BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a global partner that delivers proven end-to-end solutions to both life sciences and healthcare companies to enhance quality of life for patients with complex, chronic conditions, today announces the addition of key executives to its leadership team, raising the bar and resetting standards for managing pharmacy costs through a comprehensive suite of services for regional health plans and at-risk providers. Pharmacy management solutions are fully adaptable and scalable to meet the needs of the modern payer, with core offerings that include specialty and medical cost management, formulary and network design, custom clinical programs and data analytics to assess and maximize health outcomes.
- Bob Gilkin, SVP, AscellaHealth, will design and lead the implementation of trade and specialty strategy positioning.
- Steve Seiden, VP, AscellaHealth, will architect and direct the Company’s role as program manager of specialty pharmacy programs for limited distribution drugs (LDDs).
“We recognize that payers have conceded much, if not all, control of the pharmacy and medical benefit drug spend to a typical pharmacy benefit manager (PBM), limiting their power to direct care that improves outcomes for their members,” says Dea Belazi, CEO, AscellaHealth. “AscellaHealth can change this paradigm, bringing our end-to-end solutions and a team of experts to amplify payer-directed initiatives that enable them to wrest back the controls they may have forfeited.”
With over 20 years of experience in the pharmaceutical and healthcare industries, US WorldMeds, LLC/HEMA Biologics, LLC, RedHill Biopharma Inc., Synergy Pharmaceuticals Inc. (Bausch Health), Gemini Healthcare, LLC., AstraZeneca, LP and Coventry Health Care, Inc. (Aetna), Gilkin brings a wealth of knowledge in commercial operations and market access. His strategic leadership will drive the implementation of innovative payer strategies and models, as well as facilitate partnerships with LDD contracts.
“Joining AscellaHealth presents an exciting opportunity to tighten the healthcare value chain, especially as it relates to life improving therapies, and offer a single source, end-to-end payer solution that is far more efficient than any competitor in the marketplace,” says Gilkin. “By establishing creative partnerships with all health plan stakeholders, AscellaHealth introduces a unique opportunity for regional, smaller payers to take back control because they can provide the best care for their members. Our white-label solution for addressing all the aspects of this service essentially becomes the payer’s branded department for complete management of the pharmaceutical and medical benefit, with opportunities to address certain disease states, not simply the management of individual patients. We look forward to sharing more information soon.”
Seiden brings the expertise and strategic insights developed during his career in pharmacy operations with experience at BioMatrix Specialty Pharmacy and Elwyn Pharmacy. In this new role, Steve will focus on identifying specialty pharmacy opportunities, supporting the transition to new pharmacy fulfillment services and spearheading the development of hospital and health system service offerings.
“I look forward to contributing and furthering AscellaHealth’s mission of delivering patient-centric care,” says Seiden. “We have contracts with specialty pharmacies nationwide which are an essential component of the program, but our focus is to serve the needs of healthcare delivery systems as well as our pharmaceutical partners. This is a key market differentiator that will improve access to LDDs and specialized treatment for health plan members nationwide.”
About AscellaHealth LLC
AscellaHealth is a global partner that delivers proven end-to-end solutions to both life sciences and healthcare companies to enhance quality of life for patients with complex, chronic conditions. A dedicated team gets critical healthcare products from manufacturers to patients while ensuring an efficient flow of funds between payers and pharma. Visit www.AscellaHealth.com.
